Biotech5 hours ago
Novo Nordisk Tops Pfizer with $10B Bid for Metsera’s GLP-1 Assets
Novo Nordisk raised its bid for Metsera to €8.677 billion—11% higher than before—after Pfizer accused it of anti-competitive tactics. Metsera’s board deemed Novo’s offer a “Superior...